Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shlomo Keidar
Observed names:
Keidar Shlomo,
SHLOMO KEIDAR
Institutions:
Technion – Israel Institute of Technology,
Rambam Health Care Campus,
Rappaport Family Institute for Research in the Medical Sciences
Observed institutions:
Technion – Israel Institute of Technology,
Washington University in St. Louis,
Rambam Health Care Campus,
Maccabi Healthcare Services,
Rappaport Family Institute for Research in the Medical Sciences,
Clalit Health Services,
Rockefeller University
show all 7
OpenAlex ID:
A5113548712
Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype
2007
·
Uzi Milman
, Shany Blum
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
283
Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development
2004
·
Shlomo Keidar
, Marielle Kaplan
, et al.
·
Circulation
·
249
Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients
2005
·
Shlomo Keidar
, Aviva Gamliel-Lazarovich
, et al.
·
Circulation Research
·
197
Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL
1997
·
Osamah Hussein
, Sorina Schlezinger
, et al.
·
Atherosclerosis
·
173
Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins
1995
·
Shlomo Keidar
, Marielle Kaplan
, et al.
·
Atherosclerosis
·
151
The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient Mice
1997
·
Shlomo Keidar
, Judith Attias
, et al.
·
Biochemical and Biophysical Research Communications
·
141
Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes
2002
·
Bianca Fuhrman
, Lena Koren
, et al.
·
Atherosclerosis
·
133
Effect of Eplerenone, a Selective Aldosterone Blocker, on Blood Pressure, Serum and Macrophage Oxidative Stress, and Atherosclerosis in Apolipoprotein E–Deficient Mice
2003
·
Shlomo Keidar
, Tony Hayek
, et al.
·
Journal of Cardiovascular Pharmacology
·
130
Interactions of Platelets, Macrophages, and Lipoproteins in Hypercholesterolemia: Antiatherogenic Effects of HMG-CoA Reductase Inhibitor Therapy
1998
·
Michael Aviram
, Osamah Hussein
, et al.
·
Journal of Cardiovascular Pharmacology
·
117
Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL
2001
·
Shlomo Keidar
, Ronit Heinrich
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
116
A mouse model for human atherosclerosis: Long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice
2006
·
Raymond Coleman
, Tony Hayek
, et al.
·
Acta Histochemica
·
109
Antiatherosclerotic and Antioxidative Effects of Captopril in Apolipoprotein E-Deficient Mice
1998
·
Tony Hayek
, Judith Attias
, et al.
·
Journal of Cardiovascular Pharmacology
·
108
Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II
1994
·
Shlomo Keidar
, Marielle Kaplan
, et al.
·
Atherosclerosis
·
105
Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets
1997
·
Hussein Osamah
, Rosenblat Mira
, et al.
·
British Journal of Clinical Pharmacology
·
104
PDF
Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis
1999
·
Shlomo Keidar
, Judith Attias
, et al.
·
Atherosclerosis
·
103
Angiotensin, LDL peroxidation and atherosclerosis
1998
·
Shlomo Keidar
·
Life Sciences
·
94
Measurement of carotid artery intima-media thickness in dyslipidemic patients increases the power of traditional risk factors to predict cardiovascular events
2006
·
Damiano Baldassarre
, Mauro Amato
, et al.
·
Atherosclerosis
·
87
Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure
2005
·
Tony Karram
, Anan Abbasi
, et al.
·
American Journal of Physiology-Heart and Circulatory Physiology
·
84
The roles of serum myoglobin, total CPK, and CK-MB isoenzyme in the acute phase of myocardial infarction
1983
·
Ehud Grenadier
, Shlomo Keidar
, et al.
·
American Heart Journal
·
76
Angiotensin II–Modified LDL Is Taken Up by Macrophages Via the Scavenger Receptor, Leading to Cellular Cholesterol Accumulation
1996
·
Shlomo Keidar
, Marielle Kaplan
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
73
PDF
Increased Uptake of LDL by Oxidized Macrophages is the Result of an Initial Enhanced LDL Receptor Activity and of a Further Progressive Oxidation of LDL
1997
·
Bianca Fuhrman
, Oiknine Judith
, et al.
·
Free Radical Biology and Medicine
·
72
Apolipoprotein E and its role in aging and survival
2009
·
Francesca Bonomini
, Francesca Filippini
, et al.
·
Experimental Gerontology
·
62
Attenuation of Atherosclerosis in Apolipoprotein E-Deficient Mice by Ramipril is Dissociated from Its Antihypertensive Effect and from Potentiation of Bradykinin
2000
·
Shlomo Keidar
, Judith Attias
, et al.
·
Journal of Cardiovascular Pharmacology
·
62
Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis
2002
·
Tony Hayek
, Marielle Kaplan
, et al.
·
Atherosclerosis
·
45
Angiotensin II Injection into Mice Increases the Uptake of Oxidized LDL by Their Macrophages via a Proteoglycan-Mediated Pathway
1997
·
Shlomo Keidar
, Judith Attias
·
Biochemical and Biophysical Research Communications
·
43
Show more works
View as search
Works count:
66
Citation count:
3,564
H-index:
30
I10-index:
51
Year
Topic
Type